T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
US Global Investors
GROW
$36.6M
| $139K | ﹤0.01% |
26,700
| – | – |
|
2777
Puma Biotechnology
PBYI
$504M
| $139K | ﹤0.01% |
48,268
+33,900
| +236% | +$87.7K |
|
2778
Aqua Metals
AQMS
$9.34M
| $137K | ﹤0.01% |
453
+306
| +208% | +$69.4K |
|
2779
FTC Solar
FTCI
$43.9M
| $137K | ﹤0.01% |
2,771
-323
| -10% | -$16.1K |
|
|
HOFV
2780
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $137K | ﹤0.01% |
5,616
+4,518
| +411% | +$116K |
|
2781
Lightwave Logic
LWLG
$819M
| $137K | ﹤0.01% |
+14,300
| New | +$124K |
|
2782
Omeros
OMER
$1.45B
| $137K | ﹤0.01% |
22,855
+8,300
| +57% | +$51.8K |
|
2783
Ampco-Pittsburgh
AP
$178M
| $136K | ﹤0.01% |
21,600
| – | – |
|
|
SUP
2784
DELISTED
Superior Industries International
SUP
| $133K | ﹤0.01% |
28,600
| – | – |
|
2785
Evolution Petroleum
EPM
$141M
| $132K | ﹤0.01% |
19,400
-400
| -2% | -$2.57K |
|
|
FARM
2786
DELISTED
Farmer Brothers
FARM
| $131K | ﹤0.01% |
18,400
+5,600
| +44% | +$36.4K |
|
|
NAGE
2787
Niagen Bioscience
NAGE
$241M
| $131K | ﹤0.01% |
53,272
+17,600
| +49% | +$48.1K |
|
|
ENZ
2788
DELISTED
Enzo Biochem, Inc.
ENZ
| $130K | ﹤0.01% |
44,800
| – | – |
|
|
CARM
2789
DELISTED
Carisma Therapeutics
CARM
| $129K | ﹤0.01% |
10,725
-2,720
| -20% | -$38K |
|
2790
IZEA Worldwide
IZEA
$45.1M
| $129K | ﹤0.01% |
19,450
-6,675
| -26% | -$31.3K |
|
|
CTAQ
2791
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
| $128K | ﹤0.01% |
13,038
| – | – |
|
|
CTIC
2792
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $128K | ﹤0.01% |
27,400
-5,300
| -16% | -$15.8K |
|
2793
Curis
CRIS
$2.01M
| $127K | ﹤0.01% |
133
+23
| +21% | +$29.4K |
|
|
DRRX
2794
DELISTED
DURECT Corp
DRRX
| $127K | ﹤0.01% |
18,928
+3,736
| +25% | +$26K |
|
2795
Energy Fuels
UUUU
$3.01B
| $127K | ﹤0.01% |
13,895
+3,325
| +31% | +$25.9K |
|
2796
Aehr Test Systems
AEHR
$3.41B
| $125K | ﹤0.01% |
+12,300
| New | +$157K |
|
2797
XBiotech
XBIT
$66.2M
| $125K | ﹤0.01% |
+14,454
| New | +$145K |
|
|
LOGC
2798
DELISTED
ContextLogic
LOGC
| $125K | ﹤0.01% |
1,851
| – | – |
|
|
BRY
2799
DELISTED
Berry Corp
BRY
| $124K | ﹤0.01% |
+11,994
| New | +$114K |
|
|
AIM
2800
AIM ImmunoTech
AIM
$7.45M
| $124K | ﹤0.01% |
1,169
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.